Introduction--What is virus like particles (VLP)?

Virus-like particles (VLPs) are highly structured protein complexes that resemble a native virus capsid ranging 20–800 nm. It is made up of one or more different molecules with the ability to self-assemble and mimicking the form and size of a virus devoid of viral genome and are therefore non-infectious. VLPs in general can be either enveloped or non-enveloped, whereby in vitro assembly typically leads to protein-only shells. Due to the lack of viral genomes, these particles are non-replicative but typically retain the transduction potential of the parental viruses, which may be used for various biomedical applications.

Expression and self-assembly of the viral structural proteins of VLP can be produced in a variety of systems, including mammals, plants, insects, and bacteria. Each expression systems have several advantages such as high yield of expressed proteins, post translational modification, formation of multi-protein on the surface of VLP. VLPs have similar characteristics as nanoparticle and have the ability to mediate more biomedical functions through biotechnological methods. Therefore, VLPs have a significant function in drug delivery, genetic therapy, cellular targeting, and cancer treatment.



Picture loading failed.View the Knowledge base of virus like particles (VLP):

    - Virus-like particles (VLP) Platforms for Developing immunogens, vaccines and drug carriers
    - What is virus like particles (VLP)?
    - GM VLPx™ Virus-like particles development platform
    - Virus like particles (VLP) Expression platforms
    - Virus like particles (VLP) as immunogens/antigens of transmembrane protein (TM)
    - Virus like particles (VLP) for drug delivery
    - Virus like particles (VLP) as vaccine
    - Virus like particles (VLP) for drug discovery





GENEMEDI
Email: [email protected]   [email protected]
Telephone: +86-21-50478399   Fax: 86-21-50478399
Privacy Policy
<